{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:45:20Z","timestamp":1792043120317,"version":"4.4.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24 AI 106822"],"award-info":[{"award-number":["K24 AI 106822"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 AI007512"],"award-info":[{"award-number":["T32 AI007512"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AI110397"],"award-info":[{"award-number":["U01 AI110397"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AI126614"],"award-info":[{"award-number":["U01 AI126614"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jaip.2019.11.008","type":"journal-article","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T04:10:05Z","timestamp":1580962205000},"page":"429-440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":292,"title":["Allergic Endotypes and Phenotypes of Asthma"],"prefix":"10.1016","volume":"8","author":[{"given":"Nicole","family":"Akar-Ghibril","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Casale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Custovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanda","family":"Phipatanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2019.11.008_bib1","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.jaci.2009.10.047","article-title":"Asthma: clinical expression and molecular mechanisms","volume":"125","author":"Lemanske","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jaci.2010.11.037","article-title":"Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome","volume":"127","author":"Lotvall","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaip.2014.09.004","article-title":"The allergic asthma phenotype","volume":"2","author":"Schatz","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.11.008_bib4","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1034\/j.1398-9995.2001.t01-1-00001.x","article-title":"A\u00a0revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force","volume":"56","author":"Johansson","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.11.008_bib5","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jaci.2007.07.056","article-title":"Asthma cases attributable to atopy: results from the Third National Health and Nutrition Examination Survey","volume":"120","author":"Arbes","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib6","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1398-9995.2012.02832.x","article-title":"Untangling asthma phenotypes and endotypes","volume":"67","author":"Agache","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.11.008_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.anai.2014.04.013","article-title":"Differentiating asthma phenotypes in young adults through polyclonal cytokine profiles","volume":"113","author":"Zoratti","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.anai.2016.05.016","article-title":"Characterization of asthma endotypes: implications for therapy","volume":"117","author":"Stokes","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib9","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1034\/j.1398-9995.2002.23504.x","article-title":"Allergic vs nonallergic asthma: what makes the difference?","volume":"57","author":"Romanet-Manent","year":"2002","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.11.008_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaci.2003.10.041","article-title":"Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation","volume":"113","author":"Miranda","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1164\/rccm.200906-0896OC","article-title":"Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program","volume":"181","author":"Moore","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2019.11.008_bib12","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0140-6736(06)69290-8","article-title":"Asthma: defining of the persistent adult phenotypes","volume":"368","author":"Wenzel","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2019.11.008_bib13","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1164\/ajrccm.162.4.9912111","article-title":"A\u00a0clinical index to define risk of asthma in young children with recurrent wheezing","volume":"162","author":"Castro-Rodriguez","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2019.11.008_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2005.04.017","article-title":"Contemporaneous maturation of immunologic and respiratory functions during early childhood: implications for development of asthma prevention strategies","volume":"116","author":"Holt","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib15","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1183\/09031936.02.00103602","article-title":"The effects of respiratory infections, atopy, and breastfeeding on childhood asthma","volume":"19","author":"Oddy","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2019.11.008_bib16","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1164\/ajrccm.165.2.2104032","article-title":"A\u00a0birth cohort study of subjects at risk of atopy: twenty-two-year follow-up of wheeze and atopic status","volume":"165","author":"Rhodes","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2019.11.008_bib17","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0140-6736(06)69286-6","article-title":"Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study","volume":"368","author":"Illi","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2019.11.008_bib18","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1046\/j.1365-2222.2003.01674.x","article-title":"Relationships of allergic sensitization, total immunoglobulin E and blood eosinophils to asthma severity in children of the EGEA Study","volume":"33","author":"Siroux","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2019.11.008_bib19","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jaci.2006.08.019","article-title":"National Institutes of Health\/National Heart, Lung, and Blood Institute Severe Asthma Research Program. Features of severe asthma in school-age children: atopy and increased exhaled nitric oxide","volume":"118","author":"Fitzpatrick","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib20","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1183\/09031936.03.00261903","article-title":"The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma","volume":"22","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2019.11.008_bib21","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","article-title":"Cluster analysis and clinical asthma phenotypes","volume":"178","author":"Haldar","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2019.11.008_bib22","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1183\/09031936.00120810","article-title":"Identifying adult asthma phenotypes using a clustering approach","volume":"38","author":"Siroux","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2019.11.008_bib23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jaci.2010.11.015","article-title":"Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health\/National Heart, Lung, and Blood Institute Severe Asthma Research Program","volume":"127","author":"Fitzpatrick","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib24","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1164\/rccm.201301-0156OC","article-title":"Ten-year follow-up of cluster-based asthma phenotypes in adults: a pooled analysis of three cohorts","volume":"188","author":"Boudier","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2019.11.008_bib25","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1183\/09031936.00032713","article-title":"Genetic heterogeneity of asthma phenotypes identified by a clustering approach","volume":"43","author":"Siroux","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2019.11.008_bib26","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.jaci.2013.11.042","article-title":"Unsupervised phenotyping of Severe Asthma Research Program participants using expanded lung data","volume":"133","author":"Wu","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib27","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jaci.2014.02.006","article-title":"Classification of childhood asthma phenotypes and long-term clinical responses to inhaled anti-inflammatory medications","volume":"133","author":"Howrylak","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib28","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","article-title":"T-helper type 2-driven inflammation defines major subphenotypes of asthma","volume":"180","author":"Woodruff","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2019.11.008_bib29","first-page":"96","article-title":"The role of Pai-1 gene 4g\/5g polymorphism and diagnostic value of biomarkers in allergic and non-allergic asthma phenotype","volume":"57","author":"Lampalo","year":"2018","journal-title":"Acta Clin Croat"},{"key":"10.1016\/j.jaip.2019.11.008_bib30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1056\/NEJM199501193320301","article-title":"Asthma and wheezing in the first six years of life. The Group Health Medical Associates","volume":"332","author":"Martinez","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2019.11.008_bib31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1164\/ajrccm.160.1.9806059","article-title":"Markers of impaired growth of pulmonary function in children and adolescents","volume":"160","author":"Ulrik","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2019.11.008_bib32","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.jaci.2017.03.006","article-title":"Biologics and biomarkers for asthma, urticaria, and nasal polyposis","volume":"139","author":"Casale","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib33","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.iac.2018.06.007","article-title":"Immunoglobulin E as a biomarker in asthma","volume":"38","author":"Rath","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2019.11.008_bib34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/ACI.0b013e32835e82b6","article-title":"Pediatric asthma and development of atopy","volume":"13","author":"Custovic","year":"2013","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib35","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/all.12939","article-title":"A\u00a0new framework for the interpretation of IgE sensitization tests","volume":"71","author":"Roberts","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.11.008_bib36","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.jaci.2015.03.027","article-title":"Patterns of IgE responses to multiple allergen components and clinical symptoms at age 11 years","volume":"136","author":"Simpson","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib37","doi-asserted-by":"crossref","first-page":"e1002691","DOI":"10.1371\/journal.pmed.1002691","article-title":"Machine learning to identify pairwise interactions between specific IgE antibodies and their association with asthma: q cross-sectional analysis within a population-based birth cohort","volume":"15","author":"Fontanella","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.jaip.2019.11.008_bib38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3389\/fped.2019.00251","article-title":"Blood biomarkers of sensitization and asthma","volume":"7","author":"Sonntag","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaip.2019.11.008_bib39","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jaci.2015.08.044","article-title":"Distinguishing benign from pathologic TH2 immunity in atopic children","volume":"137","author":"Holt","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib40","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1365-2222.2008.02969.x","article-title":"IL-13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells","volume":"38","author":"Chibana","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2019.11.008_bib41","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1164\/rccm.200905-0695OC","article-title":"Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma","volume":"181","author":"Dweik","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2019.11.008_bib42","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2019.11.008_bib43","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1164\/rccm.200411-1498OC","article-title":"Exhaled nitric oxide: a predictor of steroid response","volume":"172","author":"Smith","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2019.11.008_bib44","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/thoraxjnl-2018-211540","article-title":"Tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils): a systematic review and meta-analysis","volume":"73","author":"Petsky","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2019.11.008_bib45","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1111\/all.13806","article-title":"Towards clinically applicable biomarkers for asthma\u2014an EAACI position paper","volume":"74","author":"Diamant","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.11.008_bib46","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/ppul.22769","article-title":"Induced sputum cell count and cytokine profile in atopic and non-atopic children with asthma","volume":"48","author":"Vizmanos-Lamotte","year":"2013","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jaip.2019.11.008_bib47","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12890-016-0230-4","article-title":"Periostin levels and eosinophilic inflammation in poorly-controlled asthma","volume":"16","author":"Simpson","year":"2016","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaip.2019.11.008_bib48","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S2213-2600(15)00050-8","article-title":"Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta-analysis","volume":"3","author":"Korevaar","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2019.11.008_bib49","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/all.12817","article-title":"Nasal and pharyngeal eosinophil peroxidase levels in adults with poorly controlled asthma correlate with sputum eosinophilia","volume":"71","author":"Rank","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.11.008_bib50","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3345\/kjp.2019.00318","article-title":"Nasal eosinophilia and eosinophil peroxidase in children and adolescents with rhinitis","volume":"62","author":"Choi","year":"2019","journal-title":"Korean J Pediatr"},{"key":"10.1016\/j.jaip.2019.11.008_bib51","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12948-015-0027-7","article-title":"Biomarkers and severe asthma: a critical appraisal","volume":"13","author":"Chiappori","year":"2015","journal-title":"Clin Mol Allergy"},{"key":"10.1016\/j.jaip.2019.11.008_bib52","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jaci.2012.06.025","article-title":"Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients","volume":"130","author":"Jia","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib53","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/j.jaci.2018.07.027","article-title":"Biomatrix for upper and lower airway biomarkers in patients with allergic asthma","volume":"142","author":"Zissler","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib54","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jaci.2011.11.035","article-title":"Airway epithelial cells from asthmatic children differentially express proremodeling factors","volume":"129","author":"Lopez-Guisa","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib55","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jaci.2015.08.038","article-title":"Functional variants of 17q12-21 are associated with allergic asthma but not allergic rhinitis","volume":"137","author":"Andiappan","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib56","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1046\/j.1365-2222.2003.01731.x","article-title":"Polymorphisms in the interleukin-4 and interleukin-4 receptor alpha chain genes confer susceptibility to asthma and atopy in a Caucasian population","volume":"33","author":"Beghe","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2019.11.008_bib57","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.jaci.2016.07.036","article-title":"The nasal methylome and childhood atopic asthma","volume":"139","author":"Yang","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib58","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1056\/NEJMoa032097","article-title":"Results of a home-based environmental intervention among urban children with asthma","volume":"351","author":"Morgan","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2019.11.008_bib59","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1164\/rccm.201609-1966OC","article-title":"Preventing severe asthma exacerbations in children: a randomized trial of mite-impermeable bedcovers","volume":"196","author":"Murray","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2019.11.008_bib60","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.jaci.2007.09.029","article-title":"Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007","volume":"120","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib62","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaci.2010.06.047","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision","volume":"126","author":"Brozek","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib63","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/all.12638","article-title":"Clinical contraindications to allergen immunotherapy: an EAACI position paper","volume":"70","author":"Pitsios","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.11.008_bib64","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2010.09.034","article-title":"Allergen immunotherapy: a practice parameter third update","volume":"127","author":"Cox","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib65","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.anai.2016.09.438","article-title":"Effect of asthma therapies on the natural course of asthma","volume":"117","author":"Abrams","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib66","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3389\/fped.2018.00231","article-title":"Immunotherapy and asthma in children","volume":"6","author":"Tosca","year":"2018","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaip.2019.11.008_bib67","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jaci.2015.04.047","article-title":"International consensus on allergy immunotherapy","volume":"136","author":"Jutel","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib68","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1398-9995.2012.02865.x","article-title":"International consensus on (ICON) pediatric asthma","volume":"67","author":"Papadopoulos","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.11.008_bib69","first-page":"CD001186","article-title":"Injection allergen immunotherapy for asthma","author":"Abramson","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2019.11.008_bib70","series-title":"The role of immunotherapy in the treatment of asthma","author":"Lin","year":"2018"},{"key":"10.1016\/j.jaip.2019.11.008_bib71","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1034\/j.1398-9995.2002.23498.x","article-title":"Benefits of immunotherapy with a standardized Dermatophagoides pteronyssinus extract in asthmatic children: a three-year prospective study","volume":"57","author":"Pifferi","year":"2002","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.11.008_bib72","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1081-1206(10)60004-X","article-title":"Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials","volume":"97","author":"Penagos","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib73","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13601-017-0160-0","article-title":"Allergen immunotherapy for allergic asthma: a systematic overview of systematic reviews","volume":"7","author":"Asamoah","year":"2017","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2019.11.008_bib74","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1081-1206(10)62194-1","article-title":"Preventive aspects of immunotherapy: prevention for children at risk of developing asthma","volume":"87","author":"Jacobsen","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib75","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jaci.2017.06.014","article-title":"Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy","volume":"141","author":"Valovirta","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib76","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jaci.2016.09.028","article-title":"Individualized therapy for persistent asthma in young children","volume":"138","author":"Fitzpatrick","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib77","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaci.2004.11.014","article-title":"Characterization of within-subject responses to fluticasone and montelukast in childhood asthma","volume":"115","author":"Szefler","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib78","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jaip.2017.04.038","article-title":"Biologic therapy and novel molecular targets of severe asthma","volume":"5","author":"Pepper","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.11.008_bib79","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1164\/rccm.201208-1414OC","article-title":"Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study","volume":"187","author":"Hanania","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2019.11.008_bib80","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jaip.2018.04.043","article-title":"Omalizumab effectiveness by biomarker status in patients with asthma: evidence from PROSPERO, a prospective real-world study","volume":"7","author":"Casale","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.11.008_bib81","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1542\/peds.113.4.e308","article-title":"Exhaled nitric oxide in children with asthma receiving Xolair (omalizumab), a monoclonal anti-immunoglobulin E antibody","volume":"113","author":"Silkoff","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2019.11.008_bib82","first-page":"A5949","article-title":"Type 2 biomarkers associated with dupilumab efficacy in patients with uncontrolled, moderate-to-severe asthma enrolled in the phase 3 study LIBERTY ASTHMA QUEST","volume":"197","author":"Wenzel","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2019.11.008_bib83","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1304048","article-title":"Dupilumab in persistent asthma with elevated eosinophil levels","volume":"368","author":"Wenzel","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2019.11.008_bib84","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S2213-2600(16)30031-5","article-title":"Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies","volume":"4","author":"Ortega","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2019.11.008_bib85","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa0808991","article-title":"Mepolizumab and exacerbations of refractory eosinophilic asthma","volume":"360","author":"Haldar","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2019.11.008_bib86","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.chest.2016.03.032","article-title":"Reslizumab for inadequately controlled asthma with elevated blood eosinophil levels: a randomized phase 3 study","volume":"150","author":"Bjermer","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2019.11.008_bib87","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S2213-2600(15)00042-9","article-title":"Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"3","author":"Castro","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2019.11.008_bib88","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.chest.2016.03.018","article-title":"Phase 3 study of reslizumab in patients with poorly controlled asthma: effects across a broad range of eosinophil counts","volume":"150","author":"Corren","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2019.11.008_bib89","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting beta2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2019.11.008_bib90","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S2213-2600(14)70201-2","article-title":"Benralizumab, an anti-interleukin 5 receptor alpha monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study","volume":"2","author":"Castro","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2019.11.008_bib91","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","article-title":"Benralizumab, an anti-interleukin-5 receptor alpha monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"388","author":"FitzGerald","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2019.11.008_bib92","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaci.2004.11.053","article-title":"The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation","volume":"115","author":"Holgate","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib93","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1067\/mai.2001.117880","article-title":"Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma","volume":"108","author":"Busse","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.11.008_bib94","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1009705","article-title":"Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children","volume":"364","author":"Busse","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2019.11.008_bib95","doi-asserted-by":"crossref","first-page":"E36","DOI":"10.1542\/peds.108.2.e36","article-title":"Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab)","volume":"108","author":"Milgrom","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2019.11.008_bib96","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1183\/09031936.01.00092101","article-title":"The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics","volume":"18","author":"Soler","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2019.11.008_bib97","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2222.2004.1916.x","article-title":"Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma","volume":"34","author":"Holgate","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2019.11.008_bib98","first-page":"CD003559","article-title":"Omalizumab for asthma in adults and children","author":"Normansell","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2019.11.008_bib99","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3109\/02770903.2011.648296","article-title":"A\u00a026-week, randomized, double-blind, placebo-controlled, multicenter study to evaluate the effect of omalizumab on asthma control in patients with persistent allergic asthma","volume":"49","author":"Bardelas","year":"2012","journal-title":"J\u00a0Asthma"},{"key":"10.1016\/j.jaip.2019.11.008_bib100","series-title":"The effect of omalizumab on lung function in adolescents with moderate-to-severe allergic asthma","author":"Busse","year":"2017"},{"key":"10.1016\/j.jaip.2019.11.008_bib101","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(16)30307-5","article-title":"Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting beta2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial","volume":"388","author":"Wenzel","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2019.11.008_bib102","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2019.11.008_bib103","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","article-title":"Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial","volume":"380","author":"Pavord","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2019.11.008_bib104","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2019.11.008_bib105","series-title":"Xolair (omalizumab) [package insert]","year":"2018"},{"key":"10.1016\/j.jaip.2019.11.008_bib106","series-title":"Dupixent (dupilumab) [package insert]","year":"2019"},{"key":"10.1016\/j.jaip.2019.11.008_bib107","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMoa1411776","article-title":"Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme","volume":"372","author":"Krug","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2019.11.008_bib108","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40413-018-0208-1","article-title":"Potential new targets for drug development in severe asthma","volume":"11","author":"Zhu","year":"2018","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2019.11.008_bib109","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pupt.2016.06.005","article-title":"The oral CRTh2 antagonist QAW039 (fevipiprant): a phase II study in uncontrolled allergic asthma","volume":"39","author":"Erpenbeck","year":"2016","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.jaip.2019.11.008_bib110","doi-asserted-by":"crossref","first-page":"15038","DOI":"10.1038\/s41598-017-11868-9","article-title":"A\u00a0new antagonist for CCR4 attenuates allergic lung inflammation in a mouse model of asthma","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2019.11.008_bib111","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1248\/bpb.33.1067","article-title":"RS-1748, a novel CC chemokine receptor 4 antagonist, inhibits ovalbumin-induced airway inflammation in guinea pigs","volume":"33","author":"Nakagami","year":"2010","journal-title":"Biol Pharm Bull"}],"updated-by":[{"DOI":"10.1016\/j.jaip.2020.02.026","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000}}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321981930947X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321981930947X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:22:06Z","timestamp":1761974526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221321981930947X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":110,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S221321981930947X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2019.11.008","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allergic Endotypes and Phenotypes of Asthma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2019.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}